Significance of Neuroleptic Dose and Plasma Level in the Pharmacological Treatment of Psychoses
Authors:
- Bruce M. CohenBCBruce M. Cohen
- Martin H. TeicherMTMartin H. Teicher
- 1 January 1988
- journal article
- review article
- Published by American Medical Association (AMA) in Archives of General Psychiatry
- Vol. 45 (1) , 79-91
Abstract
From JAMA Psychiatry — Significance of Neuroleptic Dose and Plasma Level in the Pharmacological Treatment of PsychosesKeywords
This publication has 102 references indexed in Scilit:
- Clonazepam – antipsychotic effect in a case of schizophrenia‐like psychosis with epilepsy and in three cases of atypical psychosisActa Psychiatrica Scandinavica, 1985
- Tissue levels of haloperidol by radioreceptor assay and behavioral effects of haloperidol in the ratLife Sciences, 1980
- High doses of fluphenazine enanthate in schizophrenia: A CONTROLLED STUDYActa Psychiatrica Scandinavica, 1978
- Section B Lorazepam in the treatment of severe anxiety and anxiety associated with psychotic conditionsCurrent Medical Research and Opinion, 1973
- Section B The treatment of neurotic and psychotic anxiety with lorazepamCurrent Medical Research and Opinion, 1973
- Rapid Tranquilization of Acutely Psychotic Patients with Intramuscular Haloperidol and ChlorpromazinePsychosomatics, 1973
- THE MANAGEMENT OF EXCITEMENT IN A GENERAL HOSPITAL PSYCHIATRIC WARD BY HIGH DOSAGE HALOPERIDOLActa Psychiatrica Scandinavica, 1971
- The Use of High Doses of Fluphenazine in the Treatment of Psychotic PatientsPsychosomatics, 1970
- Treatment of Resistant Schizophrenics With Extreme High Dosage Fluphenazine HydrochloridePsychosomatics, 1970
- Discontinuation or reduction of chemotherapy in chronic schizophrenicsJournal of Chronic Diseases, 1964